Craig is a medicine developer and entrepreneur who has spent his career improving how new therapies are translated from discovery to patients.
He has held senior clinical, scientific and leadership roles at Roche, CSL, and Moderna, where he focused on the evaluation and development of innovative medicines and helped establish and scale technology-enabled capabilities that strengthened global R&D.
Before founding Oktopi, Craig co-founded d3 Medicine (acquired by Certara) and went on to serve as President of Integrated Development at Certara, where he scaled the use of multidisciplinary, model-informed, and data-driven approaches to accelerate drug development worldwide.
Craig is an elected Fellow of the Royal College of Physicians of Edinburgh, of the Australian Academy of Health and Medical Science, and of the Australian Academy of Technological Sciences and Engineering. In 2025 he was made Member of the Order of Australia for services to pharmacology and added to the Australian COVID Honor roll.